InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ZEVRA THERAPEUTICS, INC.

ZVRA Clue Score60
United States Fiscal year ends December CIK 0001434647
$11.39 +3.55% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $11.39 +25.72% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Operating income−37.5Net income−16.5Fiscal year 2017Operating income−33.4Net income−43.4Fiscal year 2018Revenue0.0Operating income−55.9Net income−56.5Fiscal year 2019Revenue12.8Operating income−20.3Net income−24.5Fiscal year 2020Revenue13.3 +3.5%Operating income−5.6Net income−12.8EPS, diluted−3.21Fiscal year 2021Revenue28.7 +115.6%Operating income7.7Net income−8.6EPS, diluted−2.11Fiscal year 2022Revenue10.2 −64.5%Operating income−42.6Net income−26.8Fiscal year 2023Revenue27.5 +170.3%Operating income−49.6Net income−46.0Fiscal year 2024Revenue23.6 −14.0%Operating income−87.0Net income−105.5EPS, diluted−2.28Fiscal year 2025Revenue106.5 +350.9%Operating income−62.9Net income83.2EPS, diluted1.35
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a 0.0 12.8 13.3 28.7 10.2 27.5 23.6 106.5
Growth +3.5% +115.6% −64.5% +170.3% −14.0% +350.9%
Operating income −37.5 −33.4 −55.9 −20.3 −5.6 7.7 −42.6 −49.6 −87.0 −62.9
Net income −16.5 −43.4 −56.5 −24.5 −12.8 −8.6 −26.8 −46.0 −105.5 83.2
Growth
EPS, diluted n/a n/a n/a n/a −3.21 −2.11 n/a n/a −2.28 1.35

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Fiscal year 2017Fiscal year 2018Fiscal year 2019Operating margin−158.4%Net margin−191.0%Free cash flow margin−185.1%Fiscal year 2020Operating margin−42.2%Net margin−96.0%Free cash flow margin−14.8%Fiscal year 2021Operating margin27.0%Net margin−29.9%Free cash flow margin36.1%Fiscal year 2022Operating margin−418.9%Net margin−263.5%Free cash flow margin−185.1%Fiscal year 2023Operating margin−180.6%Net margin−167.7%Free cash flow margin−123.2%Fiscal year 2024Operating margin−368.5%Net margin−446.9%Free cash flow margin−295.0%Fiscal year 2025Operating margin−59.1%Net margin78.2%Free cash flow margin−2.3%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a n/a −158.4% −42.2% 27.0% −418.9% −180.6% −368.5% −59.1%
Net margin n/a n/a n/a −191.0% −96.0% −29.9% −263.5% −167.7% −446.9% 78.2%
Free cash flow margin n/a n/a n/a −185.1% −14.8% 36.1% −185.1% −123.2% −295.0% −2.3%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−29.8Capital expenditure−0.6Free cash flow−30.4Fiscal year 2017Operating cash flow−33.1Capital expenditure−0.2Free cash flow−33.3Fiscal year 2018Operating cash flow−54.2Capital expenditure−0.0Free cash flow−54.2Fiscal year 2019Operating cash flow−23.7Capital expenditure−0.0Free cash flow−23.8Fiscal year 2020Operating cash flow−1.9Capital expenditure−0.0Free cash flow−2.0Buybacks0.0Fiscal year 2021Operating cash flow10.4Capital expenditure−0.1Free cash flow10.3Buybacks−2.8Fiscal year 2022Operating cash flow−18.7Capital expenditure−0.1Free cash flow−18.8 −282.0%Buybacks−4.7Fiscal year 2023Operating cash flow−33.5Capital expenditure−0.3Free cash flow−33.8Buybacks−3.4Fiscal year 2024Operating cash flow−69.7Capital expenditure0.0Free cash flow−69.7Buybacks0.0Fiscal year 2025Operating cash flow−1.6Capital expenditure−0.8Free cash flow−2.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −29.8 −33.1 −54.2 −23.7 −1.9 10.4 −18.7 −33.5 −69.7 −1.6
Capital expenditure −0.6 −0.2 −0.0 −0.0 −0.0 −0.1 −0.1 −0.3 0.0 −0.8
Free cash flow −30.4 −33.3 −54.2 −23.8 −2.0 10.3 −18.8 −33.8 −69.7 −2.4
Growth −282.0%
Buybacks n/a n/a n/a n/a 0.0 −2.8 −4.7 −3.4 0.0 n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash16.8Shareholders’ equity−18.7Fiscal year 2017Cash10.9Total debt92.7Net cash (debt)−81.9Shareholders’ equity−57.5Fiscal year 2018Cash18.4Total debt81.4Net cash (debt)−63.0Shareholders’ equity−66.6Fiscal year 2019Cash3.2Total debt77.3Net cash (debt)−74.1Shareholders’ equity−74.5Fiscal year 2020Cash4.2Total debt67.7Net cash (debt)−63.4Shareholders’ equity−66.4Fiscal year 2021Cash112.3Shareholders’ equity101.7Fiscal year 2022Cash65.5Shareholders’ equity75.1Fiscal year 2023Cash43.0Total debt5.1Net cash (debt)38.0Shareholders’ equity61.9Debt to equity0.08Fiscal year 2024Cash33.8Total debt59.5Net cash (debt)−25.7Shareholders’ equity39.7Debt to equity1.50Fiscal year 2025Cash62.4Total debt61.9Net cash (debt)0.5Shareholders’ equity154.7Debt to equity0.40
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 16.8 10.9 18.4 3.2 4.2 112.3 65.5 43.0 33.8 62.4
Total debt n/a 92.7 81.4 77.3 67.7 n/a n/a 5.1 59.5 61.9
Net cash (debt) n/a −81.9 −63.0 −74.1 −63.4 n/a n/a 38.0 −25.7 0.5
Shareholders’ equity −18.7 −57.5 −66.6 −74.5 −66.4 101.7 75.1 61.9 39.7 154.7
Debt to equity n/a n/a n/a n/a n/a n/a n/a 0.08 1.50 0.40

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a n/a 0.0 12.8 13.3 28.7 10.2 27.5 23.6 106.5
Growth +3.5% +115.6% −64.5% +170.3% −14.0% +350.9%
n/a n/a 0.0 10.0 n/a 2.1 0.2 2.9 n/a n/a
20.5 20.6 41.8 19.4 8.8 10.2 n/a n/a n/a n/a
14.0 12.8 12.5 10.8 7.9 8.7 15.0 34.3 54.9 77.6
−37.5 −33.4 −55.9 −20.3 −5.6 7.7 −42.6 −49.6 −87.0 −62.9
Growth −650.7%
−16.5 −43.4 −56.6 −24.5 −12.8 −8.5 −26.8 −46.0 −90.1 86.7
−0.0 −0.0 −0.1 −0.0 −0.0 0.0 −0.0 0.0 15.4 3.4
−16.5 −43.4 −56.5 −24.5 −12.8 −8.6 −26.8 −46.0 −105.5 83.2
Growth
Per share
n/a n/a n/a n/a −3.21 −2.11 −0.78 −1.30 −2.28 1.40
n/a n/a n/a n/a −3.21 −2.11 n/a n/a −2.28 1.35
Growth
n/a n/a n/a n/a 4.0 29.8 34.5 35.5 46.3 55.3
n/a n/a n/a n/a 4.0 29.8 n/a n/a 46.3 57.3
Growth +647.7% +23.8%

† The diluted share count jumps at 2021 and 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 51.6% a year over five years.
  • Operating margin is down 16.9 points on five years ago, at -59.1%.
  • A net loss in 9 of 10 years on file.